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The small intestine is unreachable by endoscopic
examinations, and diseases of this portion of the intes-
tine is difficult to diagnose. Diagnostic strategies for
small intestine disease, especially obscure gastroin-
testinal (GI) bleeding, include push enteroscopy, small
intestine radiography, abdominal computed tomog-
raphy (CT), angiography, and red blood cell (RBC)
scan. However, low diagnostic yield is a common
drawback. Capsule endoscopy (CE), a wireless cap-
sule that takes images of the GI tract, is a new diag-
nostic modality for the small intestine. Many studies
have reported a higher diagnostic rate (40–83%) than
with other diagnostic methods in the setting of obscure
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Capsule endoscopy (CE) is used to diagnose small intestine disease. Many studies have shown 
a better lesion detection rate in obscure gastrointestinal (GI) bleeding than with other surveyed
techniques. Our study investigates the diagnostic value of CE in patients with suspicious small
intestine diseases. Between October 2004 and January 2006, patients who had suspected small
intestine disease underwent CE in Kaohsiung Medical University Hospital. Presenting symp-
toms included obscure GI bleeding, abdominal pain, diarrhea, microcytic anemia, and other indi-
cations. CE results were analyzed as a proportion of total lesion detection rate and also with
regard to obscure GI bleeding and abdominal pain for analysis. A total of 28 patients, including
12 males and 16 females, were enrolled for CE examination. Overall, small intestine lesions were
detected in 20 cases (71.4%), with negative findings in eight cases. For obscure GI bleeding, the
total lesion detection rate was 85.7% (12 of 14 patients) but the diagnostic rate was only 35.7%
(five of 14 cases). In patients with abdominal pain, four of seven (57.1%) had small intestine
lesions. In conclusion, CE survey has a good lesion detection rate for small intestine disease, espe-
cially for patients with obscure GI bleeding, and is helpful in the diagnosis of unexplained
abdominal pain.
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GI bleeding [1–10], while other studies have been
performed to compare sensitivity of CE with that 
of push endoscopy, small intestine radiography, or
other standard tests [2,6–10]. Video CE has been
found to be superior to push enteroscopy and small
bowel radiography in the evaluation of small bowel
diseases [2,5,7,8,10]. The complication rate (e.g. cap-
sule jammed in the GI tract) is also reported to be
favorably low at 1.5% [9]. Accordingly, our study
aims to investigate the diagnostic value of CE in
patients with suspicious small intestine diseases.
METHODS
Between October 2004 and January 2006, 28 patients
underwent CE examination in Kaohsiung Medical
University Hospital. Patients had melena, hema-
tochezia, iron-deficient anemia, abdominal pain, chro-
nic diarrhea, or family history of GI malignancy, and
had undergone upper and lower GI surveys. After 
a detailed explanation, they agreed to undergo CE
examination and submitted signed consent forms.
Most patients had had an esophagogastroduodeno-
scopic (EGD) and/or colonoscopic examination that
could not explain their symptoms. Abdominal CT,
angiography, small intestine barium study, and RBC
scan were performed only when the clinical condition
warranted it. All patients received abdominal radiog-
raphy to exclude the possibility of bowel obstruction.
None of our cases were pregnant or had pacemaker
implantation.
Equipment
The capsule endoscope (Given Imaging M2A; Given
Imaging Ltd., Yoqneam, Israel) used was 11 ˜ 26 mm 
in size, 3.7g in weight, and had a battery life of 8 hours.
The camera takes two images per second and transmits
the images via radio frequency to a sensor array in a
belt that is worn by the patient around the abdomen.
After the completion of the procedure, images were
downloaded and analyzed by proprietary software
(RAPID; Given Imaging Ltd.). The images were exam-
ined by two gastroenterologists after downloading to
a computer.
Preparation
Patients were instructed to take the laxative Fleet®
Phospho-Soda® (C.B. Fleet Co., Inc., Lynchburg, VA,
USA) 90 mL with as much water as they could toler-
ate, or polyethylene glycol and electrolytes (Klean-
Prep®; Helsinn Birex Therapeutics Ltd., Dublin,
Ireland) two packs with 1,000 mL water in each pack,
16 hours before starting the examination. All of them
fasted for at least 12 hours prior to the procedure. 
The capsule was swallowed with a glass of water and
their swallowing difficulties were monitored. Patients
were allowed to drink clear liquids 2 hours later, soft
diet 4 hours later, and a normal meal after the exami-
nation was complete. They were asked to observe
their stools to note whether or not the capsule passed
out. If not (or when obstruction signs such as nausea
or vomiting were found), the condition was recorded
and monitored with proper management such as 
follow-up with plain abdominal X-ray for the capsule
site, fasting with intravenous fluid supply, or opera-
tion for removal of the capsule.
Result reading and definition
CE findings were reviewed separately by two gastro-
enterologists. The endoscopic diagnoses of GI lesions
were according to the Atlas of Capsule Endoscopy [11].
The findings were defined as: (1) diagnostic when the
findings could explain the symptoms/signs well or be
confirmed after treatment; (2) positive when findings
showed only lesions without blood/coffee grounds or
when only blood or coffee grounds were found over
the small intestine but the cause of bleeding could
not be identified; and (3) negative when findings of
the small intestine were normal. The lesion detection
rate included diagnostic and positive findings.
RESULTS
Characteristics of patients and 
overall CE findings
Among the 28 patients who underwent CE survey, 
16 were female (57.1%) and 12 were male (42.9%). The
mean age was 56.82 ± 13.8 years (range, 31–81 years).
The main symptoms/signs were obscure GI bleeding
(n = 14, 50%), abdominal pain (n = 7, 25%), and diar-
rhea (n = 3, 10.7%). Four had other conditions (14.3%):
one had a gastric carcinoid tumor for small intestine
polyps survey; one asked for a survey due to a family
history of GI tract cancer; one had gastric and colonic
polyposis and asked for a survey of the small intestine
polyp; and one had microcytic anemia. For those with
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obscure GI bleeding, 10 presented with melena (black
stool) passage, three had hematochezia (bloody
stool), and two had anemia with occult blood in 
the stool revealed by guaiac test. The number of
other tests performed included EGD 26 cases (92.9%),
colonoscopy 25 cases (89.3%), abdominal CT 20 cases
(71.4%), small intestine series 15 cases (53.6%),
angiography six cases (21.4%), and RBC scan four
cases (14.3%). Only two patients did not receive EGD
survey due to symptoms of diarrhea and not favor-
ing upper GI origin disease. Colonoscopy was not 
performed in three patients who refused the survey.
CE findings among the patients are listed in the
Table. Overall, abnormal findings in the small intes-
tine were found in 20 of 28 patients (71.4%), while a
normal picture of the small intestine was seen in the
remaining eight. The findings included angiodys-
plasia in six (21.4%), small intestine ulcers in four
(14.3%), suspicion of small intestine tumors in three
(10.7%) (Figure 1), a positive finding of bleeding but
no definite lesions in two, small intestine polyps in
two, lymphangiectasia in one, submucosal tumor in
one (Figure 2), and active parasitic infection in one
patient (Figure 3).
As we divided these cases according to the symp-
toms, we found that CE had a good diagnostic rate 
in obscure GI bleeding and abdominal pain cases. For
the 14 obscure GI bleeding patients, the lesion detec-
tion rate was 85.7% (12 of 14 patients), but a definite
diagnosis was reached in only 35.7% (five of 14
patients). Five cases had small intestine lesions visu-
alized but no blood or coffee ground-like substance
was found. Two patients presented with small intes-
tine coffee ground substance but no lesions were
detected due to blood coverage.
Among the seven patients who presented with
abdominal pain, four (57.1%) were diagnosed with
small intestine lesions, including Crohn’s disease in
one, small intestine ulcers in one, and jejunum tumor
in two patients.
Of the 28 patients, two had the capsule jam just
above the lesion, and one had prolonged gastric
emptying and the image recording stopped at the
ileum. Our complication rate was 7.1%, with an
incomplete data rate of 10.7%. Four patients received
further operative management. One patient who had
parasites in the small intestine received antiparasitic
agents for treatment. Other patients received medical
management according to their symptoms.
Capsule endoscopy
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Table. Capsule endoscopic findings
Symptoms Findings n
Obscure GI bleeding 14
Angiodysplasia 6*
Suspected small 1
intestine tumor
Small intestine ulcers 2†
Bleeding without 2
defined lesion
Third-portion 1†
duodenal polyp
Negative 2
Abdominal pain 7
Suspected jejunal tumor 2
Small intestine ulcers 1
Submucosal tumor 1
Negative 2
Diarrhea 3
Crohn’s disease 1
Lymphangiectasia 1
Parasites 1
Others 4
Family history of Normal 1
GI malignancy
Microcytic anemia Normal 1
Gastric/colon polyp Negative 1
Gastric carcinoid Jejunal polyps 1
tumor
*Two patients’ images showed active bleeding from lesion as
diagnostic, but four had positive findings with angiodyspla-
sia but no bleeding when examined; †lesion with active bleed-
ing noted during examination. GI = gastrointestinal.
Figure 1. Jejunal tumor in a 64-year-old man with tarry stool.
The arrows indicate the tumor site.
For findings other than small intestine findings,
four recorded stomach polyps, four had gastric ero-
sions, one had a colonic polyp, one had diverticulum
at the ascending colon, and one patient who had small
intestine angiodysplasia also had colonic angiodys-
plasia. Neither discomfort nor swallowing difficulty
was noted among these patients.
DISCUSSION
CE is a newly developed diagnostic method for small
intestine disease. In our report, the overall lesion
detection rate was 71.4%. For those with obscure GI
bleeding, the lesion detection rate was 85.7%, but the
diagnostic rate was 35.7%. Many studies have also
evaluated the diagnostic value of CE in obscure GI
bleeding, and the lesion detection rate ranged from
40% to 83% [1–10]. The diagnostic rate in our study
was found to be lower (35.7%), but including the pos-
itive finding cases, the lesion detection rate (85.7%)
was good. In Chao et al’s study [3], the lesion detection
rate was 81% and the diagnostic rate was 37%, and
the data found to be close to our study. This is because
the exact source of bleeding is difficult to establish
when bleeding stops during an examination, though
possible lesions (e.g. angiodysplasia, small intestine
ulcers or tumors) may be detected, and if multiple
lesions are detected, then this makes it even more 
difficult to focus on the main bleeding source.
In contrast, when there is excessive blood or cof-
fee ground-like substance in the lumen, CE can only
detect the site of bleeding and the definite lesion can
be masked. Accordingly, it is useful to combine other
diagnostic strategies such as small intestine radio-
graphy and abdominal CT to make a more accurate
diagnosis. Additionally, a second-look examination
may help to improve the detection rate and, in fact,
one study has shown that repeated CE should be
considered in patients with persistent obscure GI
bleeding when the initial study is negative or incon-
clusive [4]. However, this is expensive and no study
has yet been conducted to evaluate its cost effective-
ness and benefit yield.
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Figure 2. External compression over the distal jejunum suspected to be a submucosal tumor.
Figure 3. Parasite found in the jejunum and ileum.
Capsule endoscopy
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Most small intestine bleeding is self-limiting. For
those with recurrent or severe bleeding, the source 
of bleeding revealed by CE helps in further operative
management.
CE also has a good detection rate for those with
abdominal pain where small intestine lesions are sus-
pected. In our study, the detection rate was 57.1%
(four of seven patients). Most studies mainly discuss
the diagnostic rate in obscure GI bleeding cases. In
abdominal pain cases where upper GI and colonic
problems have been ruled out, CE also has a good
lesion detection rate. Two cases were diagnosed with
small intestine tumors with an image of the capsule
showing much residual food in the lumen, narrowing
the field to hyperemic, ulcerative, edematous mucosal
change, and capsule stasis in the lumen. To-and-fro
moving of the CE over the pre-lesion area may give
false information of segmental lesions, so imaging
findings may give us information about the presence
of small intestine mucosal tumor lesions.
Many studies have described CE as possessing
good detection value in Crohn’s disease [3,5,9].
Positive findings range from areas of denuded villi,
mucosal breaks to gross ulceration. However, other
etiologies must be excluded before reaching the diag-
nosis of Crohn’s disease, but a biopsy cannot be per-
formed during CE examination and such limitations
remain.
There remain some problems about the procedure
and preparation that need to be solved. Firstly, some
conditions such as gastric bubbles, residual food, and
blood may interfere with the view. Some reports have
indicated that gastric bubbles may be improved after
simethicone use [9]. Residual food may hint at intes-
tinal obstruction or mucosal ulcerations. The presence
of blood may give us information about bleeding
sites even when the main lesion cannot be identified.
Besides these, good preparation is important. Some
patients, especially those with diabetic neuropathy,
have delayed bowel movement and constipation. We
suggest that such patients fast for longer, take more
water or even laxatives, although further observation
and study should be made to evaluate the effects of
these measures. Secondly, can what we see completely
explain the patients’ problems or not? For example,
can it explain the cause of bleeding when we see
angiodysplasia in multiple areas of the small bowel?
How probable is it to have a masked bleeding lesion?
Most patients in stable condition have self-limiting
small intestine bleeding. For those with severe or
recurring bleeding, angiography or repeated CE sur-
vey may give us more information [4]. Again, further
study is needed to evaluate the effect of second-look
CE. Thirdly, incomplete CE survey is an important
issue. We found the capsule jammed in the stenotic
lumen in two cases, and another patient had delayed
gastric emptying and the capsule ran out of battery
power before reaching the ileocecal valve. Patients
suffer when undergoing an operation for capsule
removal and it is important to rule out the possibility
of intestinal stenosis by abdominal radiography or
small intestine series before subjecting them to such
an operation. Otherwise, an operation should be 
previously planned in candidate patients who have
been preinformed and who have already agreed to
undergo it. Finally, CE cannot be used for treatment
or collection of tissue for pathology, and its high cost
is generally acknowledged. The capsule may need to
be more delicately designed in the future. 
ACKNOWLEDGMENTS
This work was supported by a grant from Kaohsiung
Medical University Hospital (M094025).
REFERENCES
1. Raj M, Goh KL, Chua CJ, et al. Wireless capsule
endoscopy for diagnosis of small intestinal lesions. 
Dig Endosc 2004;16:134–7.
2. Neu B, Ell C, May A, et al. Capsule endoscopy versus
standard tests in influencing management of obscure
digestive bleeding: results from a German multicenter
trial. Am J Gastroenterol 2005;100:1736–42.
3. Chao CC, Ng JYT, Mo LR. Capsule endoscopy for gas-
trointestinal bleeding with an obscure etiology. J Formos
Med Assoc 2005;104:659–65.
4. Jones BH, Fleischer DE, Sharma VK, et al. Yield of
repeat wireless video capsule endoscopy in patients with
obscure gastrointestinal bleeding. Am J Gastroenterol
2005;100:1058–64.
5. Marmo R, Rotondano G, Piscopo R, et al. Meta-analysis:
capsule enteroscopy vs. conventional modalities in
diagnosis of small bowel diseases. Aliment Pharmacol
Ther 2005;22:595–604.
6. Ge ZZ, Hu YB, Gao YJ, et al. Clinical application 
of wireless capsule endoscopy. Chin Dig Dis 2003;4:
89–92.
7. Triester SL, Leighton JA, Leontiadis GI, et al. A meta-
analysis of the yield of capsule endoscopy compared 
to other diagnostic modalities in patients with obscure
gastrointestinal bleeding. Am J Gastroenterol 2005;100:
2407–18.
8. Hadithi M, Heine GD, Jacobs MA, et al. A prospective
study comparing video capsule endoscopy with double-
balloon enteroscopy in patients with obscure gastroin-
testinal bleeding. Am J Gastroenterol 2006;101:52–7.
9. Remedios ML, Appleyard M. Capsule endoscopy: cur-
rent indications and future prospects. Intern Med J
2005;35:234–9.
10. Mata A, Bordas JM, Feu F, et al. Wireless capsule
endoscopy in patients with obscure gastrointestinal
bleeding: a comparative study with push enteroscopy.
Aliment Pharmacol Ther 2004;20:189–94.
11. Halpern M, Jacob H (eds). Atlas of Capsule Endoscopy,
1st edition. Yoqneam, Israel: Given Imaging, Ltd., 2002.
Kaohsiung J Med Sci September 2006 • Vol 22 • No 9430
M.K. Liu, F.J. Yu, J.Y. Wu, et al
Kaohsiung J Med Sci September 2006 • Vol 22 • No 9 431
 !"VR==P==OT=
 !"VR==T==R=
 !"#$%&'
 !"!#$ %&'()
 UMT !"#$NMM
 !"#$%&'()*=
OU= !"#
 
N
= = 
N
= = 
NIO
= = 
N
= = 
PIQ
 
PIQ
= = 
NIQ
= = 
NIQ
 !"!#$ %= = =
N
 != = =
P
 !"#$
O
 !"#$%= == = =
Q
 !"!= = !
 !"#$%&'()*+,-./0123456!"#$%7)*89
 !"#$%&'()*+,-./01!"#!23456789$%&
 !"=OMMQ==NM==OMMS==N= !"#$%&'()*+,-
 !"#$%&'()*+,-./0123456789:;9:<9=
 !"#$%&'()*+,-./0123456789:;<=>3?
 !"#$%&'()*+,-. /0=OU= !"=NO== EQOKVBF
=NS== ERTKNBF= !"#$=OM== ETNKQBF= !"#$%U=
 !"#$%&'()*+,-./#0123453=NO== EURKTBF
 !"#"$%&!=R==EPRKTBF !"#$%&Q= !"#$%
 =RTKNB !"#$%&'()*+,-./01&23456789
 !"#$%&
  !"#$% &'()*+,-./ 0123 0145
E !=OMMSXOOWQORPNF
